Executive Director, Clinical Research, Oncology at Eikon Therapeutics

Millbrae, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, OncologyIndustries

Requirements

MD or DO degree with significant experience in Oncology
Minimum of 10+ years of clinical experience
Significant experience in clinical practice with direct patient care (preferably in Oncology)
Proven track record in leading clinical trials, including medical monitoring of early and late clinical trials and managing complex projects
Minimum of 3 days a week onsite presence (or more as business needs require) in either California or New Jersey offices

Responsibilities

Design and conduct early-stage or late-stage clinical development trials, including assessing clinical safety and efficacy data, performing medical monitoring, and other study-related clinical activities
Work closely with biomarker, discovery, and translational research scientists
Provide leadership for Clinical teams in a matrix environment
Interpret reports, prepare oral and written results of product research, and participate in the discussion of strategies formulated within Eikon's disease areas
Collaborate closely with Clinical Science and other relevant functions within Eikon and potential partners, including discovery, translational, and biomarker research scientists, toxicologists, clinical pharmacologists, drug safety specialists, regulatory representatives, Global Clinical Operations, and other support functions
Establish strong working relationships and collaborations with external study investigators, key opinion leaders in drug development, and external alliance partners
Work closely with functional partners (Data Management, Clinical Operations, Biostatistics, Regulatory) to ensure an integrated and strategic approach to flawless execution and systematic oversight of study protocol(s) in clinical development
Work in partnership with colleague study responsible physicians and clinical scientists to ensure development of high-quality study protocols including use of consistent processes/standards across studies
Work closely with functional partners to address protocol questions from Health Authorities and Ethics Committees in a consistent fashion

Skills

Clinical Research

Oncology

Drug Development

Clinical Trials

Study Design

Medical Expertise

Strategic Leadership

Operational Oversight

Physician

Eikon Therapeutics

Biotech startup developing innovative medicines

About Eikon Therapeutics

Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.

Hayward, CaliforniaHeadquarters

2019Year Founded

$750.8MTotal Funding

SERIES_CCompany Stage

AI & Machine Learning, BiotechnologyIndustries

201-500Employees

Benefits

401(k) Company Match

Medical (premiums covered by Eikon at 95%)

Dental Insurance

Vision Insurance

Mental Health Support

Unlimited Paid Time Off

Paid Holidays

Life Insurance

Enhanced Parental Leave

Daily subsidized lunch program

Risks

Competition from biotech unicorns like Abogen Biosciences is increasing.

Integrating new clinical-stage assets may delay drug development timelines.

Reliance on SMT technology risks obsolescence from emerging molecular biology technologies.

Differentiation

Eikon uses proprietary single-molecule tracking for real-time protein movement analysis.

The company integrates AI and automation for large-scale molecular interaction studies.

Eikon's diverse team combines expertise in science, engineering, and technology.

Upsides

Growing interest in SMT technology boosts Eikon's drug discovery potential.

Partnerships with AI firms enhance Eikon's drug candidate identification.

Rising demand for precision medicine aligns with Eikon's focus on dynamic biology.

Land your dream remote job 3x faster with AI

Try Jobo Free